Skip to main content
. 2016 Jul 18;37(10):1147–1155. doi: 10.1017/ice.2016.132

TABLE 3.

Comorbidity of MERS-CoV cases at KAMC-Riyadh (mid-June to mid-September, 2015)

Variable Patients (N=87) HCWs (N=43) Overall (N=130) P value
Any comorbid diseases
No 1 (1%) 25 (58%) 26 (20%) <.001
Yes 86 (99%) 18 (42%) 104 (80%)
Number of comorbid diseases
Mean (SD) 5.6 (2.3) 2.0 (1.1) 4.9 (2.5) <.001
1–3 diseases 16 (19%) 16 (89%) 32 (31%) <.001
4–6 diseases 41 (48%) 2 (11%) 43 (41%)
≥7 diseases 29 (34%) 0 (0%) 29 (28%)
Respiratory comorbid diseases
Any respiratory disease 22 (25%) 6 (14%) 28 (22%) .14
Asthma 10 (12%) 3 (7%) 13 (10%) .54
Chronic obstructive pulmonary disease 14 (16%) 3 (7%) 17 (13%) .15
Bronchiectasis 3 (3%) 0 (0%) 3 (2%) .55
Tuberculosis 5 (6%) 0 (0%) 5 (4%) .17
Allergic rhinitis 1 (1%) 2 (5%) 3 (2%) .25
Other chronic respiratory disease 6 (7%) 1 (2%) 7 (5%) .42
Other comorbid diseases
Hypertension 70 (81%) 4 (9%) 74 (57%) <.001
Diabetes 68 (78%) 3 (7%) 71 (55%) <.001
Heart disease 45 (52%) 0 (0%) 45 (35%) <.001
Chronic kidney disease 38 (44%) 0 (0%) 38 (29%) <.001
Hemodialysis 13 (15%) 0 (0%) 13 (10%) .01
Immunosuppressive disease 36 (41%) 0 (0%) 36 (28%) <.001
Neurologic disease 24 (28%) 1 (2%) 25 (19%) <.01
Stroke 21 (24%) 1 (2%) 22 (17%) <.01
Cancer 19 (22%) 0 (0%) 19 (15%) <.01
Previous surgeries 15 (17%) 3 (7%) 18 (14%) .11
Dyslipidemia 17 (20%) 0 (0%) 17 (13%) <.01
Hypothyroidism 12 (14%) 3 (7%) 15 (12%) .38
Other metabolic disease 9 (10%) 2 (5%) 11 (9%) .34
Blood disease 7 (8%) 3 (7%) 10 (8%) >.99
Urinary tract infection 8 (9%) 2 (5%) 10 (8%) .50
Chronic liver disease 7 (8%) 1 (2%) 8 (6%) .27
Benign prostatic hyperplasia 7 (8%) 0 (0%) 7 (5%) .10
Psychiatric disease 4 (5%) 0 (0%) 4 (3%) .30
Rheumatoid 1 (1%) 0 (0%) 1 (1%) >.99
Other chronic disease 17 (20%) 4 (9%) 21 (16%) .14
Bed bound 8 (9%) 0 (0%) 8 (6%) .05
Pregnancy 0 (0%) 1 (2%) 1 (1%) .33

NOTE. The column heads represent the maximum number; the denominator was sometimes lower when data were missing. HCW, healthcare worker; KAMC, King Abdulaziz Medical City; MERS-CoV, Middle East respiratory syndrome coronavirus.